Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.

Phipps JP, Haas KM.

J Infect Dis. 2019 Jan 7;219(2):323-334. doi: 10.1093/infdis/jiy506.

PMID:
30289460
2.

Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.

Haro MA, Dyevoich AM, Phipps JP, Haas KM.

Cancer Res. 2019 Jan 1;79(1):159-170. doi: 10.1158/0008-5472.CAN-18-0981. Epub 2018 Sep 17.

PMID:
30224373
3.

CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.

Haas KM, Johnson KL, Phipps JP, Do C.

J Immunol. 2018 Mar 1;200(5):1671-1681. doi: 10.4049/jimmunol.1701578. Epub 2018 Jan 26.

PMID:
29374074
4.

PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.

McKay JT, Haro MA, Daly CA, Yammani RD, Pang B, Swords WE, Haas KM.

J Immunol. 2017 Sep 15;199(6):2020-2029. doi: 10.4049/jimmunol.1700555. Epub 2017 Aug 2.

5.

PD-1 Suppresses Development of Humoral Responses That Protect against Tn-Bearing Tumors.

Haro MA, Littrell CA, Yin Z, Huang X, Haas KM.

Cancer Immunol Res. 2016 Dec;4(12):1027-1037. Epub 2016 Nov 8.

6.

Evolution of protein phosphorylation across 18 fungal species.

Studer RA, Rodriguez-Mias RA, Haas KM, Hsu JI, Viéitez C, Solé C, Swaney DL, Stanford LB, Liachko I, Böttcher R, Dunham MJ, de Nadal E, Posas F, Beltrao P, Villén J.

Science. 2016 Oct 14;354(6309):229-232.

PMID:
27738172
7.

Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.

Qin Q, Yin Z, Wu X, Haas KM, Huang X.

Biomaterials. 2016 Sep;101:189-98. doi: 10.1016/j.biomaterials.2016.05.050. Epub 2016 Jun 2.

8.

Billion-fold rate enhancement of urethane polymerization via the photothermal effect of plasmonic gold nanoparticles.

Haas KM, Lear BJ.

Chem Sci. 2015 Nov 1;6(11):6462-6467. doi: 10.1039/c5sc02149a. Epub 2015 Jul 31.

9.

The Proteomic Landscape of Triple-Negative Breast Cancer.

Lawrence RT, Perez EM, Hernández D, Miller CP, Haas KM, Irie HY, Lee SI, Blau CA, Villén J.

Cell Rep. 2015 May 12;11(6):990. doi: 10.1016/j.celrep.2015.04.059. Epub 2015 May 12. No abstract available.

10.

B-1 lymphocytes in mice and nonhuman primates.

Haas KM.

Ann N Y Acad Sci. 2015 Dec;1362:98-109. doi: 10.1111/nyas.12760. Epub 2015 Apr 30. Review.

11.

The proteomic landscape of triple-negative breast cancer.

Lawrence RT, Perez EM, Hernández D, Miller CP, Haas KM, Irie HY, Lee SI, Blau CA, Villén J.

Cell Rep. 2015 Apr 28;11(4):630-44. doi: 10.1016/j.celrep.2015.03.050. Epub 2015 Apr 16. Erratum in: Cell Rep. 2015 May 12;11(6):990.

12.

PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism.

McKay JT, Egan RP, Yammani RD, Chen L, Shin T, Yagita H, Haas KM.

J Immunol. 2015 Mar 1;194(5):2289-99. doi: 10.4049/jimmunol.1401673. Epub 2015 Jan 26.

13.

Fe3O4 nanoparticles as robust photothermal agents for driving high barrier reactions under ambient conditions.

Johnson RJ, Haas KM, Lear BJ.

Chem Commun (Camb). 2015;51(2):417-20. doi: 10.1039/c4cc07966c.

PMID:
25406790
14.

C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.

Yammani RD, Leyva MA, Jennings RN, Haas KM.

J Immunol. 2014 Dec 1;193(11):5434-43. doi: 10.4049/jimmunol.1401462. Epub 2014 Oct 22.

15.

The effects of diet-induced obesity on B cell function.

Shaikh SR, Haas KM, Beck MA, Teague H.

Clin Exp Immunol. 2015 Jan;179(1):90-9. doi: 10.1111/cei.12444. Review.

16.

A practical recipe to survey phosphoproteomes.

Edelman WC, Haas KM, Hsu JI, Lawrence RT, Villén J.

Methods Mol Biol. 2014;1156:389-405. doi: 10.1007/978-1-4939-0685-7_26.

PMID:
24792003
17.

Aging promotes B-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: implications for vaccine protection in older adults.

Haas KM, Blevins MW, High KP, Pang B, Swords WE, Yammani RD.

J Infect Dis. 2014 Jan 1;209(1):87-97. doi: 10.1093/infdis/jit442. Epub 2013 Aug 20.

18.

Degradation of polypropylene carbonate through plasmonic heating.

Haas KM, Lear BJ.

Nanoscale. 2013 Jun 21;5(12):5247-51. doi: 10.1039/c3nr01498c.

PMID:
23657671
19.

Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens.

Yammani RD, Haas KM.

J Immunol. 2013 Apr 1;190(7):3100-8. doi: 10.4049/jimmunol.1203058. Epub 2013 Mar 1.

20.

A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.

Poe JC, Minard-Colin V, Kountikov EI, Haas KM, Tedder TF.

J Immunol. 2012 Sep 1;189(5):2318-25. doi: 10.4049/jimmunol.1201000. Epub 2012 Jul 23.

21.

The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation.

Crump KE, Juneau DG, Poole LB, Haas KM, Grayson JM.

Eur J Immunol. 2012 Aug;42(8):2152-64. doi: 10.1002/eji.201142289.

22.

Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens.

Haas KM.

J Immunol. 2011 Nov 15;187(10):5183-95. doi: 10.4049/jimmunol.1101990. Epub 2011 Oct 14.

23.

Partial splenectomy but not total splenectomy preserves immunoglobulin M memory B cells in mice.

Tracy ET, Haas KM, Gentry T, Danko M, Roberts JL, Kurtzberg J, Rice HE.

J Pediatr Surg. 2011 Sep;46(9):1706-10. doi: 10.1016/j.jpedsurg.2011.04.020.

PMID:
21929978
24.

Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice.

Poe JC, Smith SH, Haas KM, Yanaba K, Tsubata T, Matsushita T, Tedder TF.

PLoS One. 2011;6(7):e22464. doi: 10.1371/journal.pone.0022464. Epub 2011 Jul 25.

25.

B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.

Smith SH, Haas KM, Poe JC, Yanaba K, Ward CD, Migone TS, Tedder TF.

Int Immunol. 2010 Aug;22(8):681-91. doi: 10.1093/intimm/dxq055. Epub 2010 May 31.

26.

Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.

Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, Okochi H, Fujimoto M, Tedder TF.

J Immunol. 2010 May 1;184(9):4789-800. doi: 10.4049/jimmunol.0902391. Epub 2010 Apr 5.

27.

CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.

Haas KM, Poe JC, Tedder TF.

J Immunol. 2009 Sep 15;183(6):3661-71. doi: 10.4049/jimmunol.0901218. Epub 2009 Aug 26.

28.

Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.

Minard-Colin V, Xiu Y, Poe JC, Horikawa M, Magro CM, Hamaguchi Y, Haas KM, Tedder TF.

Blood. 2008 Aug 15;112(4):1205-13. doi: 10.1182/blood-2008-01-135160. Epub 2008 May 21.

29.

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF.

Immunity. 2008 May;28(5):639-50. doi: 10.1016/j.immuni.2008.03.017.

30.

Maternal effects influencing DNA endoreduplication in developing endosperm of Zea mays.

Kowles RV, Yerk GL, Haas KM, Phillips RL.

Genome. 1997 Dec;40(6):798-805.

PMID:
18464865
31.

Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.

DiLillo DJ, Hamaguchi Y, Ueda Y, Yang K, Uchida J, Haas KM, Kelsoe G, Tedder TF.

J Immunol. 2008 Jan 1;180(1):361-71.

32.

Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis.

Zabel MD, Heikenwalder M, Prinz M, Arrighi I, Schwarz P, Kranich J, von Teichman A, Haas KM, Zeller N, Tedder TF, Weis JH, Aguzzi A.

J Immunol. 2007 Nov 1;179(9):6144-52.

33.

In vivo murine CD23 destabilization enhances CD23 shedding and IgE synthesis.

Ford JW, Kilmon MA, Haas KM, Shelburne AE, Chan-Li Y, Conrad DH.

Cell Immunol. 2006 Oct;243(2):107-17. Epub 2007 Feb 26.

PMID:
17324389
34.

CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo.

Haas KM, Sen S, Sanford IG, Miller AS, Poe JC, Tedder TF.

J Immunol. 2006 Sep 1;177(5):3063-73.

35.

The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner.

Pongratz G, McAlees JW, Conrad DH, Erbe RS, Haas KM, Sanders VM.

J Immunol. 2006 Sep 1;177(5):2926-38.

36.
37.

CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.

Tedder TF, Poe JC, Haas KM.

Adv Immunol. 2005;88:1-50. Review.

PMID:
16227086
39.

Role of the CD19 and CD21/35 receptor complex in innate immunity, host defense and autoimmunity.

Haas KM, Tedder TF.

Adv Exp Med Biol. 2005;560:125-39. Review. No abstract available.

PMID:
15934172
40.

The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.

Hamaguchi Y, Uchida J, Cain DW, Venturi GM, Poe JC, Haas KM, Tedder TF.

J Immunol. 2005 Apr 1;174(7):4389-99.

41.
42.

CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.

Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, Sanford IG, Bock CB, Fujimoto M, Tedder TF.

Nat Immunol. 2004 Oct;5(10):1078-87. Epub 2004 Sep 19.

PMID:
15378059
43.

mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma.

Katenkamp K, Berndt A, Hindermann W, Wunderlich H, Haas KM, Borsi L, Zardi L, Kosmehl H.

J Pathol. 2004 Jul;203(3):771-9.

PMID:
15221936
44.

The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy.

Uchida J, Hamaguchi Y, Oliver JA, Ravetch JV, Poe JC, Haas KM, Tedder TF.

J Exp Med. 2004 Jun 21;199(12):1659-69.

45.

Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression.

Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF.

J Immunol. 2004 May 15;172(10):5833-7.

46.

Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells.

Hilger I, Leistner Y, Berndt A, Fritsche C, Haas KM, Kosmehl H, Kaiser WA.

Eur Radiol. 2004 Jun;14(6):1124-9. Epub 2004 Apr 30.

PMID:
15118831
48.

Mouse CD20 expression and function.

Uchida J, Lee Y, Hasegawa M, Liang Y, Bradney A, Oliver JA, Bowen K, Steeber DA, Haas KM, Poe JC, Tedder TF.

Int Immunol. 2004 Jan;16(1):119-29.

PMID:
14688067
49.

Differential in vivo and in vitro expression of ED-B+ fibronectin in adult human hematopoiesis.

Vogel W, Berndt A, Müller A, Dahse R, Haas KM, Borsi L, Zardi L, Kosmehl H.

Int J Mol Med. 2003 Dec;12(6):831-7.

PMID:
14612953
50.

Identification and characterization of a novel regulatory factor: IgA-inducing protein.

Austin AS, Haas KM, Naugler SM, Bajer AA, Garcia-Tapia D, Estes DM.

J Immunol. 2003 Aug 1;171(3):1336-42.

Supplemental Content

Support Center